Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection.
about
New perspectives in occult hepatitis C virus infectionA New Twist to a Chronic HCV Infection: Occult Hepatitis COccult Hepatitis C Virus Infection Revisited with Ultrasensitive Real-Time PCR AssayCell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cellsOccult persistence and lymphotropism of hepatitis C virus infectionOccult hepatitis C: how convincing are the current data?Prevalence and follow-up of occult HCV infection in an Italian population free of clinically detectable infectious liver disease.Persistence of hepatitis C virus during and after otherwise clinically successful treatment of chronic hepatitis C with standard pegylated interferon α-2b and ribavirin therapyPatient-derived hepatitis C virus inhibits CD4⁺ but not CD8⁺ T lymphocyte proliferation in primary T cells.Persistence of Hepatitis C Virus Traces after Spontaneous Resolution of Hepatitis CSporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responsesReview: Occult hepatitis C virus infection: still remains a controversy.Hepatitis C virus persisting after clinically apparent sustained virological response to antiviral therapy retains infectivity in vitro.Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates.Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells.Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus.
P2860
Q22305491-BAD8CB24-E52E-4DE7-A4DA-450AC6C29F3FQ26798189-BDCD6D94-5828-409B-B378-4F4914A0F90BQ27486401-375CCF98-B4E0-438B-80DC-4C877A87E612Q27487385-0341DA5E-5992-452A-BDD5-AA7DF9165821Q27488897-D0712C24-9F20-418D-84CC-AE45F8D2CFBAQ33395436-35265B47-203D-4F1F-AF88-6DA67A9D9DF8Q34395796-11F01F86-B5E8-4328-9E50-B0EF4E60D855Q35053440-D3637E8B-F2F2-4FA7-AB93-FEC6148D156AQ35760616-098C156D-3FBE-43B2-A5D5-ECD5B5FB426BQ35810396-DF988970-AA00-4E9E-B051-E6770DCA411AQ36103046-A5EC1439-1CEB-47F4-8804-532130BA9704Q38217470-F92E00F9-759A-499E-ADC2-0A379C10D1CDQ42984822-FA8BFF9E-1F39-4012-A015-3CEB3C435488Q42990115-B9298D25-BBAB-4BAA-AE03-A393F75E8F74Q42996222-B96D384D-D01D-4DE9-AE3D-109FDB098317Q43037993-F3C95409-6A6F-492D-94E2-7B0F22B3C145
P2860
Antagonistic expression of hepatitis C virus and alpha interferon in lymphoid cells during persistent occult infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Antagonistic expression of hep ...... g persistent occult infection.
@en
Antagonistic expression of hep ...... g persistent occult infection.
@nl
type
label
Antagonistic expression of hep ...... g persistent occult infection.
@en
Antagonistic expression of hep ...... g persistent occult infection.
@nl
prefLabel
Antagonistic expression of hep ...... g persistent occult infection.
@en
Antagonistic expression of hep ...... g persistent occult infection.
@nl
P2093
P2860
P1476
Antagonistic expression of hep ...... ng persistent occult infection
@en
P2093
Michalak TI
Mulrooney-Cousins PM
Zalewska M
P2860
P304
P356
10.1111/J.1365-2893.2006.00834.X
P577
2007-08-01T00:00:00Z